Björklund Pharma

  • Home
  • Company
  • Science & Innovation
  • Publications
  • Media
  • Contact
    • Contact Form

Bone metabolism

Product Candidate

Ostecibum

Osteoporosis is a bone metabolism disorder. Ostecibum is a dietary supplement optimally designed for lowering osteoporosis risk in menopausal women. The capsules contain calcium citrate, vitamin D3, and root extracts of wild yam and Chinese angelica. These herbs contain natural compounds (including β-sitosterol, diosgenin, flavonoids, methoxy esters, and organic acids) with similar effects as estrogen and progestogen. Contraindications for the product include allergy to its components, lactation, pregnancy, malignant neoplasms (estrogen-dependent), severe renal failure, and urolithiasis.

Recent Posts

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment
  • Zinc Deficiency: A Globally Widespread Ailment

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment
  • Zinc Deficiency: A Globally Widespread Ailment
  • Email
  • Facebook
  • Google+
  • LinkedIn
  • Twitter
  • YouTube

RSS CONEM News

  • DAJTEMU
  • Better Brain Health – We Are What We Eat
  • Zinc, Copper, and Autism Spectrum Disorder
  • Nutritional Minerals and the Periodic Table
  • Semey Revisited: The legacy of nuclear testing in Kazakhstan

Contact Us

Björklund Pharma AS
Toften 24
8610 Mo i Rana
Norway

Phone: +47 411 11 942
Email: info(at)bjorklundpharma.com

Copyright © 2023 Björklund Pharma AS